Zu den von der DGKL ausgetragenen Sessions zählen:
Clinical Mass Spectrometry Metabolites (DGKL)
LC-MS3 yields unparalleled diagnostic specificity in primary newborn screening for congenital adrenal hyperplasia
A. Gaudl, Leipzig/DE, L. Lehmicke, Leipzig/DE, U. Ceglarek, Leipzig/DE
Lipidomics biomarker discovery – a case study
A. Bendt, Singapore/SG
Therapeutic Drug Monitoring of Orphan Drugs by LC-MS/MS
K. Habler, Munich/DE
CE-certified and LDT assays in laboratory medicine: Instrumental analysis facing Scylla and Charybdis
C. Seger, St. Gallen/CH
Insights into the platelets from patients with critical progression of COVID-19 - Questions and possible consequences?
I. Birschmann, Bad Oeynhausen/DE, M. Wolny, Bad Oeynhausen/DE, S. Rozanova, Bochum/DE, M. Zimmermann, Bad Oeynhausen/DE, C. Knabbe, Bad Oeynhausen/DE, K. Marcus, Bad Oeynhausen/DE
Changes in the Proteome of Platelets from Patients with Critical Progression of COVID-19 - Implementation and challenges
K. Marcus-Alic, Bochum/DE
Novel Biomarkers for Precision Medicine in Sepsis: A Focus on Protein Interactome
B. Koos, Bochum/DE
Den Bereich KI und Algorithmen decken folgfende DGKL-Vorträge ab:
Machine Learning in Laboratory Medicine: IFCC Special report
A. Bietenbeck, Munich/DE
Machine learning-based clinical decision support systems
A. Tolios, Vienna/AT
Neural networks for interpretation of serum protein electrophoresis
J. Gebauer, Bad Salzuflen/DE, J. Böhm, Passau/DE
AMPEL-CDSS: hospital-wide decision support for the early detection of sepsis patients and other conditions
M. Federbusch, Leipzig/DE, T. Kirsten, Leipzig/DE, M. Schmidt, Leipzig/DE, D. Steinbach, Leipzig/DE, A. Twrdik, Leipzig/DE
Mit dem Thema Liquid Profiling in der Präzisionsmedizin wiederum befassen sich folgende DGKL-Sessions:
Liquid Biopsy in precision oncology
R. Claus, Augsburg/DE
Circulating tumor DNA applications in patients with B-cell lymphomas
S. K. Alig, Munich/DE
Clinical need for liquid biopsy in the molecular tumor board
L. Illert, Munich/DE
Variability of Liquid Biopsy during Exercise and over the Course of Invasive Surgery
P. Simon, Mainz/DE
Circulating tumor DNA applications in patients with B-cell lymphomas
S. K. Alig, Munich/DE
Clinical need for liquid biopsy in the molecular tumor board
L. Illert, Munich/DE
Variability of Liquid Biopsy during Exercise and over the Course of Invasive Surgery
P. Simon, Mainz/DE
Gender-Hinweis. Die in diesem Text verwendeten Personenbezeichnungen beziehen sich immer gleichermaßen auf weibliche, männliche und diverse Personen. Auf eine Doppel/Dreifachnennung und gegenderte Bezeichnungen wird zugunsten einer besseren Lesbarkeit verzichtet.
